Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.

Ankle-brachial index Arterial stiffness Cardiovascular disease Central pressure augmentation Osteoarthritis Phenotypes Ultrasonography

Journal

BMC rheumatology
ISSN: 2520-1026
Titre abrégé: BMC Rheumatol
Pays: England
ID NLM: 101738571

Informations de publication

Date de publication:
2019
Historique:
received: 01 03 2019
accepted: 24 07 2019
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 15 8 2019
Statut: epublish

Résumé

The objective of this study was to explore the associations between ultrasonographic and radiographic joint scores and levels of arterial CVD risk markers in patients with osteoarthritis (OA). Secondly, to compare the levels of arterial CVD risk markers between OA phenotypes and controls. The "Musculoskeletal pain in Ullensaker" Study (MUST) invited residents of Ullensaker municipality with self-reported OA to a medical examination. OA was defined according to the American College of Rheumatology (ACR) criteria and phenotyped based on joint distribution. Joints of the hands, hips and knees were examined by ultrasonography and conventional radiography, and scored for osteosteophytes. Hands were also scored for inflammation by grey scale (GS) synovitis and power Doppler (PD) signal. Control populations were a cohort of inhabitants of Oslo (OCP), and for external validation, a UK community-based register (UKPC).Pulse pressure augmentation index (AIx) and pulse wave velocity (PWV) were measured using the Sphygmocor apparatus (Atcor®). Ankel-brachial index (ABI) was estimated in a subset of patients. In separate adjusted regression models we explored the associations between ultrasonography and radiograph joint scores and AIx, PWV and ABI. CVD risk markers were also compared between phenotypes of OA and controls in adjusted analyses. Three hundred and sixty six persons with OA were included (mean age (range); 63.0 (42.0-75.0)), (females (%); 264 (72)). Of these, 155 (42.3%) had isolated hand OA, 111 (30.3%) had isolated lower limb OA and 100 (27.3%) had generalized OA. 108 persons were included in the OCP and 963 persons in the UKPC; (mean age (range); OCP: 57.2 (40.4-70.4), UKPC: 63.9 (40.0-75.0), females (%); OCP: 47 (43.5), UKPC: 543 (56.4%). Hand osteophytes were associated with AIx while GS and PD scores were not related to CVD risk markers. All OA phenotypes had higher levels of AIx compared to OCP in adjusted analyses. External validation against UKPC confirmed these findings. Hand osteophytes might be related to higher risk of CVD. People with OA had higher augmented central pressure compared to controls.Words 330.

Sections du résumé

BACKGROUND BACKGROUND
The objective of this study was to explore the associations between ultrasonographic and radiographic joint scores and levels of arterial CVD risk markers in patients with osteoarthritis (OA). Secondly, to compare the levels of arterial CVD risk markers between OA phenotypes and controls.
METHOD METHODS
The "Musculoskeletal pain in Ullensaker" Study (MUST) invited residents of Ullensaker municipality with self-reported OA to a medical examination. OA was defined according to the American College of Rheumatology (ACR) criteria and phenotyped based on joint distribution. Joints of the hands, hips and knees were examined by ultrasonography and conventional radiography, and scored for osteosteophytes. Hands were also scored for inflammation by grey scale (GS) synovitis and power Doppler (PD) signal. Control populations were a cohort of inhabitants of Oslo (OCP), and for external validation, a UK community-based register (UKPC).Pulse pressure augmentation index (AIx) and pulse wave velocity (PWV) were measured using the Sphygmocor apparatus (Atcor®). Ankel-brachial index (ABI) was estimated in a subset of patients. In separate adjusted regression models we explored the associations between ultrasonography and radiograph joint scores and AIx, PWV and ABI. CVD risk markers were also compared between phenotypes of OA and controls in adjusted analyses.
RESULTS RESULTS
Three hundred and sixty six persons with OA were included (mean age (range); 63.0 (42.0-75.0)), (females (%); 264 (72)). Of these, 155 (42.3%) had isolated hand OA, 111 (30.3%) had isolated lower limb OA and 100 (27.3%) had generalized OA. 108 persons were included in the OCP and 963 persons in the UKPC; (mean age (range); OCP: 57.2 (40.4-70.4), UKPC: 63.9 (40.0-75.0), females (%); OCP: 47 (43.5), UKPC: 543 (56.4%). Hand osteophytes were associated with AIx while GS and PD scores were not related to CVD risk markers. All OA phenotypes had higher levels of AIx compared to OCP in adjusted analyses. External validation against UKPC confirmed these findings.
CONCLUSIONS CONCLUSIONS
Hand osteophytes might be related to higher risk of CVD. People with OA had higher augmented central pressure compared to controls.Words 330.

Identifiants

pubmed: 31410391
doi: 10.1186/s41927-019-0081-8
pii: 81
pmc: PMC6686275
doi:

Types de publication

Journal Article

Langues

eng

Pagination

33

Subventions

Organisme : British Heart Foundation
ID : FS/12/8/29377
Pays : United Kingdom

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

J Am Coll Cardiol. 2005 Nov 1;46(9):1753-60
pubmed: 16256881
Osteoarthritis Cartilage. 2007;15 Suppl A:A1-56
pubmed: 17320422
Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S120-4
pubmed: 19026154
Ann Rheum Dis. 2009 Nov;68(11):1696-700
pubmed: 19033292
Eur Heart J. 2010 Aug;31(15):1865-71
pubmed: 20197424
Arthritis Rheum. 1991 May;34(5):505-14
pubmed: 2025304
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Ann Rheum Dis. 2011 May;70(5):812-7
pubmed: 21288959
Arthritis Rheum. 1990 Nov;33(11):1601-10
pubmed: 2242058
Ann Rheum Dis. 2013 May;72(5):646-51
pubmed: 22563029
Circulation. 2012 Dec 11;126(24):2890-909
pubmed: 23159553
BMC Musculoskelet Disord. 2013 Jul 05;14:201
pubmed: 23826721
Ann Rheum Dis. 2015 Jan;74(1):74-81
pubmed: 24047870
Osteoarthritis Cartilage. 2014 Jan;22(1):91-4
pubmed: 24216057
Ann Rheum Dis. 2015 Apr;74(4):752-6
pubmed: 24385204
Ann Rheum Dis. 2016 May;75(5):825-30
pubmed: 25834142
Vascular. 2016 Feb;24(1):70-7
pubmed: 25925906
Eur J Prev Cardiol. 2016 Jun;23(9):938-46
pubmed: 26464295
BMC Musculoskelet Disord. 2016 Aug 11;17:335
pubmed: 27515421
Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939
pubmed: 27692125
J Nutr Health Aging. 2018;22(3):371-376
pubmed: 29484350
Arthritis Rheum. 1986 Aug;29(8):1039-49
pubmed: 3741515

Auteurs

S A Provan (SA)

Department of Rheumatology, Oslo, Norway.

S Rollefstad (S)

2Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

E Ikdahl (E)

2Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

A Mathiessen (A)

Department of Rheumatology, Oslo, Norway.

I J Berg (IJ)

Department of Rheumatology, Oslo, Norway.

I Eeg (I)

Department of Rheumatology, Oslo, Norway.

I B Wilkinson (IB)

3Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

C M McEniery (CM)

3Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

T K Kvien (TK)

Department of Rheumatology, Oslo, Norway.

H B Hammer (HB)

Department of Rheumatology, Oslo, Norway.

N Østerås (N)

4National Resource Centre for rehabilitation in Rheumatology. Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

I K Haugen (IK)

Department of Rheumatology, Oslo, Norway.

A G Semb (AG)

2Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Classifications MeSH